Poor trial results may prompt maker to pull ALS drug from market
by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t
Updated on: March 20,2024
15

Poor trial results may prompt maker to pull ALS drug from market
by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t
Updated on:March 20,2024
15
